110 related articles for article (PubMed ID: 23277164)
1. Variations in pill appearance of antiepileptic drugs and the risk of nonadherence.
Kesselheim AS; Misono AS; Shrank WH; Greene JA; Doherty M; Avorn J; Choudhry NK
JAMA Intern Med; 2013 Feb; 173(3):202-8. PubMed ID: 23277164
[TBL] [Abstract][Full Text] [Related]
2. Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies.
Kesselheim AS; Bykov K; Avorn J; Tong A; Doherty M; Choudhry NK
Ann Intern Med; 2014 Jul; 161(2):96-103. PubMed ID: 25023248
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
Hansen RN; Nguyen HP; Sullivan SD
Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
[TBL] [Abstract][Full Text] [Related]
4. Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs.
Devine ST; Weisbart E; Barron J; Behm A
Curr Med Res Opin; 2010 Feb; 26(2):455-63. PubMed ID: 20014974
[TBL] [Abstract][Full Text] [Related]
5. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study.
Faught E; Duh MS; Weiner JR; Guérin A; Cunnington MC
Neurology; 2008 Nov; 71(20):1572-8. PubMed ID: 18565827
[TBL] [Abstract][Full Text] [Related]
6. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
7. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
Zachry WM; Doan QD; Clewell JD; Smith BJ
Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
[TBL] [Abstract][Full Text] [Related]
8. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
[TBL] [Abstract][Full Text] [Related]
9. Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
Rascati KL; Richards KM; Johnsrud MT; Mann TA
Pharmacotherapy; 2009 Jul; 29(7):769-74. PubMed ID: 19558250
[TBL] [Abstract][Full Text] [Related]
10. Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study.
Handoko KB; Zwart-van Rijkom JE; Hermens WA; Souverein PC; Egberts TC
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):189-96. PubMed ID: 17036373
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with poor seizure control and increased side effects after switching to generic antiepileptic drugs.
Bautista RE; Gonzales W; Jain D
Epilepsy Res; 2011 Jun; 95(1-2):158-67. PubMed ID: 21530177
[TBL] [Abstract][Full Text] [Related]
12. Refilling and switching of antiepileptic drugs and seizure-related events.
Gagne JJ; Avorn J; Shrank WH; Schneeweiss S
Clin Pharmacol Ther; 2010 Sep; 88(3):347-53. PubMed ID: 20631693
[TBL] [Abstract][Full Text] [Related]
13. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
14. Risk of aplastic anemia in patients using antiepileptic drugs.
Handoko KB; Souverein PC; van Staa TP; Meyboom RH; Leufkens HG; Egberts TC; van den Bemt PM
Epilepsia; 2006 Jul; 47(7):1232-6. PubMed ID: 16886988
[TBL] [Abstract][Full Text] [Related]
15. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
Davis KL; Candrilli SD; Edin HM
Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
[TBL] [Abstract][Full Text] [Related]
17. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
[TBL] [Abstract][Full Text] [Related]
18. Warnings without guidance: patient responses to an FDA warning about ezetimibe.
Shrank WH; Choudhry NK; Tong A; Myers J; Fischer MA; Swanton K; Slezak J; Brennan TA; Liberman JN; Moffit S; Avorn J; Carpenter D
Med Care; 2012 Jun; 50(6):479-84. PubMed ID: 22581012
[TBL] [Abstract][Full Text] [Related]
19. Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study.
Tsiropoulos I; Andersen M; Nymark T; Lauritsen J; Gaist D; Hallas J
Epilepsia; 2008 Dec; 49(12):2092-9. PubMed ID: 18479399
[TBL] [Abstract][Full Text] [Related]
20. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
